RNA-seq
RyboDyn, Moffitt Cancer Center Expand Immuno-Oncology Partnership
RyboDyn will use its RyboCypher RNA-seq platform and Moffitt's tumor bank to pursue a new class of cancer immunotherapy targets.
Glioma Study Unravels Molecular Features of Tumors From Adolescent, Young Adult Patients
Individuals with low-grade tumors and pediatric glioma-like alterations tended to have better progression-free survival and overall outcomes than others.
The Karolinska Institute spinout recently secured SEK 11.7 million ($1.2 million) in funding to further develop and commercialize its BaseCode technology.
Acute Myeloid Leukemia Differentiation States Characterized With Single-Cell Reference Atlas
Researchers mapped single-cell gene expression in healthy hematopoietic cells, using this atlas to find AML differentiation patterns and related driver genes.
Basic Genomics Closes $1.2M Investment Round to Support RNA Analysis Tech
The company has not disclosed details of its BaseCode technology, which it claims to enable accurate, accessible, and cost-effective analysis of RNA molecules.